CD8A and neoplasm: Consequently, treatment of cancer patients with PD-1/PD-L1 and CTLA-4 ICIs can relieve this tumour-intrinsic suppression and allow cytotoxic CD8 T-lymphocytes to re-enter the tumour and clear the tumour cells [5].